Combination of Ibrutinib and As2O3 in the Treatment of CLL
Peking University People's Hospital
Peking University People's Hospital
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
SCRI Development Innovations, LLC